Terumo starts US-Japan stent trial
This article was originally published in Clinica
Executive Summary
Terumo Medical has initiated a trial of its Misago peripheral self-expanding stent for use in the superficial femoral artery (SFA). Called OSPREY, the study will simultaneously enrol patients in the US and Japan.